Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Klaus Bosslet
Characterization of a Re-Engineered, Mesothelin-targetedPseudomonasexotoxin Fusion Protein for Lung Cancer Therapy
Molecular Oncology
Cancer Research
Medicine
Oncology
Genetics
Molecular Medicine
Related publications
Mesothelin-Mediated Targeting of Adenoviral Vectors for Ovarian Cancer Gene Therapy
Gene Therapy
Molecular Medicine
Genetics
Molecular Biology
Characterization of Engineered Human Lung Tissue
Antibody-Nkg2d Ligand (Rae-1Beta) Fusion Protein for Breast Cancer Therapy
Mouse Interleukin-12/FasTI: A Novel Bi-Functional Fusion Protein for Cancer Immuno/Gene Therapy
International Journal of Oncology
Cancer Research
Oncology
Clinic Application of Tissue Engineered Bronchus for Lung Cancer Treatment
Journal of Thoracic Disease
Pulmonary
Respiratory Medicine
Inhibition of Mesothelin–CA-125 Interaction in Patients With Mesothelioma by the Anti-Mesothelin Monoclonal Antibody MORAb-009: Implications for Cancer Therapy
Lung Cancer
Cancer Research
Oncology
Respiratory Medicine
Pulmonary
Engineered Nanoparticles Induce Cell Apoptosis: Potential for Cancer Therapy
Oncotarget
Oncology
Protein-Protein Interactions for Cancer Therapy
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
Mesothelin Targeted Cancer Immunotherapy
European Journal of Cancer
Cancer Research
Oncology
